IP Library Granted Patent US 9,427,277
Granted Patent B2
US 9,427,277 · App. 13/352,210 · Granted Aug 30, 2016

Ablative treatment of the heart to improve patient outcomes following surgery

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,427,277
App. No.
13/352,210
Granted
Aug 30, 2016
Kind
B2
Abstract

Devices and methods are described for ablation of cardiac tissue for treating cardiac arrhythmias, such as atrial fibrillation. Devices may include a tissue contacting member for contacting epicardial tissue and securing the ablation device to the epicardial tissue and an ablation member for ablating the tissue. Suction apertures attach the contacting member to the epicardial surface with sufficient strength to stabilize the tissue with the device. The devices and methods can be used to ablate epicardial tissue in the vicinity of a pulmonary vein or to ablate cardiac tissues in other locations on a heart. A combined pacing and ablation probe is described for treating cardiac arrhythmia by: advancing the probe through an incision into the vicinity of the patient's heart, verifying at least one location of a cardiac parasympathetic ganglion, and applying ablation energy to the cardiac parasympathetic ganglion.

Claims (16)

1. A method of treating a cardiac arrhythmia in a heart of a patient, comprising:

locating a cardiac parasympathetic ganglion by applying a pacing signal to a localized region of cardiac tissue using a combined pacing and ablation probe having a pair of pacing electrodes located on a distal portion thereof and observing a relaxation response in the heart due to stimulation of the cardiac parasympathetic ganglion by the pacing signal; and

applying ablation energy to the cardiac parasympathetic ganglion through an ablation electrode on the distal portion of the combined pacing and ablation probe, wherein the ablation electrode is positioned surrounding the pacing electrodes and the ablation electrode is electrically insulated from the pacing electrodes.

2. The method of treating the cardiac arrhythmia of claim 1 , wherein the combined pacing and ablation probe is maintained in position between the locating step and the ablation step.

3. The method of treating the cardiac arrhythmia of claim 1 , wherein the relaxation response in the heart is an observed reduction in heart rate due to stimulation of the cardiac parasympathetic ganglion by the pacing signal.

4. The method of treating the cardiac arrhythmia of claim 1 , wherein the pacing signal is applied at a pacing interval of approximately 50-60 ms.

5. The method of treating the cardiac arrhythmia of claim 1 , further comprising performing a cardiac or thoracic surgery procedure.

6. The method of treating the cardiac arrhythmia of claim 5 wherein the patient is not symptomatic for cardiac arrhythmia, but is determined to be at high risk for developing cardiac arrhythmia as a sequella to the cardiac or thoracic surgical procedure.

7. The method of treating the cardiac arrhythmia of claim 1 wherein the patient is symptomatic for cardiac arrhythmia.

8. The method of treating the cardiac arrhythmia of claim 1 wherein the patient is not symptomatic for cardiac arrhythmia, but is determined to be at high risk for developing cardiac arrhythmia due to a concomitant medical condition.

9. The method of treating the cardiac arrhythmia of claim 1 , wherein the combined pacing and ablation probe is inserted into the patient through an incision.

10. The method of treating the cardiac arrhythmia of claim 1 , wherein the ablation electrode has a greater surface area than the pacing electrodes.

11. The method of treating the cardiac arrhythmia of claim 1 , wherein the ablation electrode is made of a semiconducting material.

12. The method of treating the cardiac arrhythmia of claim 1 , further comprising:

sensing a temperature of the ablation electrode with a temperature sensor located on the combined pacing and ablation probe.

13. The method of treating the cardiac arrhythmia of claim 1 , wherein the pacing electrodes and the ablation electrode are located on a distal portion of an elongated shaft and the method further comprises inserting the elongated shaft of the combined pacing and ablation probe through an incision in the patient and contacting the heart of the patient with the pacing electrodes and the ablation electrode.

Assignments (5)
MERGER AND CHANGE OF NAME Recorded Jan 28, 2026
From: ENDOSCOPIC TECHNOLOGIES, INC.; NINERS MERGER SUB, LLC
To: ENDOSCOPIC TECHNOLOGIES, LLC
Reel/Frame 073620/0158 →
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2024
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC; SENTREHEART LLC
Reel/Frame 066256/0797 →
SECURITY INTEREST Recorded Jan 10, 2024
From: ATRICURE, INC.; ATRICURE, LLC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066267/0896 →
SECURITY INTEREST Recorded Dec 18, 2018
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 047951/0496 →
SECOND AMENDED AND RESTATED JOINT INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 25, 2016
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 038520/0062 →